Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.

Bart Barlogie; Robert A Kyle; Kenneth C Anderson; Philip R Greipp; Hillard M Lazarus; David D Hurd; Jason McCoy; Dennis F Moore; Shaker R Dakhil; Keith S Lanier

doi:10.1200/JCO.2005.04.5807

Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.

Identifier:nobleid.org/w1/20260522/EB0DD31F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EB0DD31F.svg?ark=w1%2F20260522%2FEB0DD31F)](https://nobleid.org/work/w1/20260522/EB0DD31F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.

Identifier:nobleid.org/w1/20260522/EB0DD31F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EB0DD31F.svg?ark=w1%2F20260522%2FEB0DD31F)](https://nobleid.org/work/w1/20260522/EB0DD31F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work